All Experimentica sites are now CIR-accredited

Experimentica’s sites have gained CIR accreditation for 2026-2028, enabling eligible French companies to benefit from CIR-covered preclinical ophthalmic research services.

Experimentica’s Kuopio and Vilnius sites are now both CIR-accredited for 2026–2028. Our Kuopio site has held the accreditation since 2020, and with the addition of our Vilnius site, French biotech and pharmaceutical companies can access an expanded range of non-GLP preclinical ophthalmic studies and forthcoming GLP preclinical studies under our CIR-covered service offering.

The French Crédit d’Impôt Recherche (CIR) is a tax incentive supporting companies that invest in research and development. Our accreditation enables eligible French companies to include qualifying R&D services purchased from Experimentica in their CIR tax credit claims. Eligibility depends on the customer’s R&D project and the applicable French tax regulations.